An estradiol derivative or an estratopone derivative containing sustained release intraocular implant as well as related methods of manufacturing

Details for Australian Patent Application No. 2005244216 (hide)

Owner Allergan, Inc.

Inventors Dickinson, Paul W.; Shiah, Jane Guo

Agent Davies Collison Cave

Pub. Number AU-A-2005244216

PCT Pub. Number WO2005/110366

Priority 10/837,379 30.04.04 US

Filing date 21 April 2005

Wipo publication date 24 November 2005

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

Event Publications

23 November 2006 PCT application entered the National Phase

  PCT publication WO2005/110366 Priority application(s): WO2005/110366

18 November 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005244221-Surgical implants and related methods

2005244214-Topical methadone compositions and methods for using the same